GlassScriptPhysician profile
Tanya Miguel Evers
NPI 1396910196
$789.19
in general payments reported to CMS, 2019-2025
23 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.88 · 2020: $27.65 · 2021: $104 · 2022: $65.32 · 2023: $121 · 2024: $128 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $149.91 | 2019-2025 | |
| Pfizer INC. | $116.99 | 2020-2023 | |
| Novo Nordisk INC | $54.72 | 2022-2025 | Ozempic |
| Exact Sciences Corporation | $54.29 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $49.09 | 2025 | |
| Lilly USA, LLC | $28.68 | 2025 | Zepbound, Mounjaro |
| Neurelis, INC. | $28.63 | 2023-2025 | Valtoco |
| Sanofi Pasteur INC. | $25.22 | 2019 | |
| Glaxosmithkline, LLC. | $25.09 | 2024 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $24.78 | 2024 | |
| Eisai INC. | $24.52 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.96 | 2025 | |
| Amgen INC. | $23.87 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.35 | 2024 | Strensiq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.32 | 2023 | Xifaxan, Trulance |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.60 | 2023 | Freestyle Libre 3 |
| Cvrx, INC. | $15.88 | 2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $15.11 | 2021 | |
| Philips North America LLC | $14.75 | 2024 | (Ck7) Extended Holter |
| Astellas Pharma US INC | $14.64 | 2023 | Myrbetriq |
| Tris Pharma INC | $14.63 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.26 | 2025 | Lifevest |
| Janssen Biotech, INC. | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Evers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.